New Jersey
Civil Justice Institute

  • Helpful Links
  • Contact Us
  • HOME
  • ABOUT US
    • Our Mission
    • Membership
    • Our Staff
  • ISSUES & ADVOCACY
  • OUR WORK IN THE COURTS
  • NEWSROOM
  • GET INVOLVED

Fairness. Justice.
Rule of Law.

Decision from New Jersey Supreme Court on Accutane Appeal

October 3, 2018News, Recent NewsNew Jersey Supreme CourtNJCJI

We had more good news coming out of the New Jersey Supreme Court this morning in the other Accutane appeal that was heard earlier this year.  Today’s decision addressed the applicability of New Jersey’s Product Liability (PLA) to Accutane claims consolidated in MCL in Atlantic County, and the adequacy of Roche’s warning label under the PLA.

 

The Court held that New Jersey has the most significant interest with respect to the MCL cases and the PLA therefore applies to all cases consolidated in the MCL: “New Jersey’s interest in consistent, fair, and reliable outcomes cannot be achieved by applying a diverse quilt of laws to so many cases that share common issues of fact.”  This is a reasonable rule that enhances predictability for litigation brought by out-of-state plaintiffs against New Jersey-based businesses.

 

We are also pleased to see the Court affirm the strength of the PLA adequacy of warning, which requires a heightened standard of “clear and convincing” evidence that a label warning is inadequate, and find that Roche’s warnings were adequate as a matter of law.

 

Today’s decision affirms the primacy of the federal regulatory process in adequacy of warnings, and ensures that our state’s pharmaceutical companies will continue to enjoy the protection of the PLA from unmeritorious product-liability litigation from out-of-state residents.

 

This is yet another New Jersey Supreme Court decision to uphold Superior Court Judge Nelson Johnson’s analysis in the ongoing Accutane litigation.  Earlier this year, Judge Johnson’s careful scrutiny of flawed expert testimony was ultimately vindicated in a decision that formally aligned New Jersey’s standard with the federal Daubert standard, consistent with repeated arguments by NJCJI.

Newsletter Sign Up




© 2022 NJCJI. All rights reserved.

Follow us on:

  • twitter
  • linkedin

TWITTER FEED TWITTER FEED

  • https://t.co/DlWbCRFBea, Jul 1
  • https://t.co/xl0stnCZfj NJCJI President Anthony Anastasio testified this week about the implications of NJ Senate… https://t.co/o55d5pA29b, Jun 24
  • https://t.co/x2z9vrW707 Thank you to @PPAGInc, @GenovaBurns, and @PBWTLaw for your support of the 2022 Spring Event!, Jun 21
  • Institute for Legal Reform Releases Update on Third-Party Litigation Funding https://t.co/UQDqeUQ712, Apr 15
  • The American Tort Reform Association issued a report about the National Association of Attorneys General. https://t.co/14sYVCKPrY, Apr 8

    QUICK CONTACT



    Please enter the code as shown below

    captcha

    New Jersey Civil Justice Institute | 112 West State Street, Trenton, NJ 08608 | office: (609) 218-6331 | info@civiljusticenj.org